MedPath

Hemay Pharmaceutical Pty Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

Phase 1
Conditions
Inflammatory Bowel Disease
Interventions
Drug: placebo
First Posted Date
2015-11-11
Last Posted Date
2017-10-24
Lead Sponsor
Hemay Pharmaceutical PTY. LTD.
Target Recruit Count
82
Registration Number
NCT02603185
Locations
🇦🇺

CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia

© Copyright 2025. All Rights Reserved by MedPath